SITTNER & NELSON, LLC - NOVAVAX INC ownership

Quarter-by-quarter ownership
SITTNER & NELSON, LLC ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2023$4,873
-2.5%
6730.0%0.00%0.0%
Q2 2023$5,000
+11.0%
673
+3.5%
0.00%0.0%
Q1 2023$4,505
-32.6%
6500.0%0.00%
-25.0%
Q4 2022$6,682
-44.3%
6500.0%0.00%
-50.0%
Q3 2022$12,000
-63.6%
6500.0%0.01%
-63.6%
Q2 2022$33,000
-31.2%
6500.0%0.02%
-21.4%
Q1 2022$48,000
-48.4%
6500.0%0.03%
-48.1%
Q4 2021$93,000
-31.1%
6500.0%0.05%
-37.9%
Q3 2021$135,000
-2.2%
6500.0%0.09%
-10.3%
Q2 2021$138,000
+68.3%
650
+44.4%
0.10%
+59.0%
Q1 2021$82,000
+192.9%
450
+80.0%
0.06%
+144.0%
Q4 2020$28,0002500.02%
Other shareholders
NOVAVAX INC shareholders Q4 2023
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 90,000$4,629,0001.95%
Affinity Asset Advisors, LLC 85,000$4,372,0001.84%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 6,814$132,500,0001.38%
Mendel Capital Management LLC 23,835$1,226,0001.37%
Faithward Advisors, LLC 80,143$4,122,0000.92%
Coatue Management 1,241,716$63,861,0000.77%
Rock Springs Capital Management LP 475,100$24,434,0000.71%
SECTOR GAMMA AS 55,324$2,845,0000.64%
SevenOneSeven Capital Management 5,103$262,0000.61%
SECTORAL ASSET MANAGEMENT INC 49,200$2,530,0000.51%
View complete list of NOVAVAX INC shareholders